Valuation: Avinger, Inc.

Capitalization 2.71M 2.3M 2.14M 2.01M 3.74M 248M 3.96M 24.43M 9.68M 117M 10.15M 9.94M 429M P/E ratio 2022
-0.25x
P/E ratio 2023 -0.19x
Enterprise value 12.83M 10.92M 10.14M 9.51M 17.7M 1.17B 18.77M 116M 45.87M 555M 48.1M 47.12M 2.03B EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
More valuation ratios * Estimated data
Dynamic Chart
1 year 0.36
Extreme 0.363
0.82
3 years 0.36
Extreme 0.363
24.3
5 years 0.36
Extreme 0.363
801
10 years 0.36
Extreme 0.363
1,000,000
More quotes
Manager TitleAgeSince
General Counsel - 2016-09-30
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-20.74%-.--%-16.84%-97.37% 1.52M
-0.29%-5.40%+7.96%-29.18% 15.53B
-1.04%+3.66%+51.76%-31.90% 3.5B
+0.14%-5.48%-0.85%-45.99% 1.73B
-0.12%-3.99%+16.48%-19.87% 1.67B
-0.63%-0.50%-26.14% - 1.46B
+0.65%+1.29%+75.13%+196.83% 1.32B
-1.01%+5.86%+321.33%+181.29% 740M
+1.13%+3.31% - - 293M
-0.17%-3.92%-48.91%+186.67% 257M
Average -2.21%+2.64%+42.21%+42.56% 2.65B
Weighted average by Cap. -0.33%-1.91%+23.55%-9.52%
See all sector performances

Financials

2022 2023
Net sales 8.27M 7.04M 6.54M 6.13M 11.42M 758M 12.1M 74.66M 29.59M 358M 31.02M 30.39M 1.31B 7.65M 6.51M 6.05M 5.67M 10.56M 701M 11.2M 69.06M 27.36M 331M 28.69M 28.11M 1.21B
Net income -17.62M -15M -13.93M -13.06M -24.32M -1.61B -25.78M -159M -63.02M -762M -66.08M -64.73M -2.79B -18.32M -15.59M -14.48M -13.58M -25.28M -1.68B -26.8M -165M -65.51M -793M -68.7M -67.29M -2.9B
Net Debt 1.76M 1.49M 1.39M 1.3M 2.42M 161M 2.57M 15.85M 6.28M 75.98M 6.58M 6.45M 278M 10.12M 8.61M 8M 7.5M 13.97M 927M 14.81M 91.33M 36.19M 438M 37.95M 37.17M 1.6B
More financial data * Estimated data
Logo Avinger, Inc.
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Employees
70
More about the company